文献速递基础与转化研究新药、器械与细胞基因治疗研发

通过肝脏靶向疗法挽救小鼠戊二酸尿症I型

Rescue of glutaric aciduria type I in mice by liver-directed therapies.
PubMed 文献 · Sci Transl Med · 2023-04-19

戊二酸尿症I型(GA-1)由戊二酰辅酶A脱氢酶(GCDH)缺陷所致。研究利用赖氨酸分解代谢通路敲除小鼠及肝细胞移植实验,发现脑内毒性GA-1代谢物来源于肝脏。通过腺相关病毒替换缺陷Gcdh基因或CRISPR删除Aass基因阻断赖氨酸降解通路,两种肝脏靶向基因疗法均挽救了GA-1小鼠模型的脑表型和致死表型。

要点

  • 脑内毒性GA-1代谢物来源于肝脏,而非局部产生。
  • AAV介导的Gcdh基因替换可挽救GA-1小鼠脑与致死表型。
  • CRISPR删除Aass基因阻断赖氨酸降解通路同样实现挽救。

核心结论

  • GA-1小鼠脑内毒性代谢物来源于肝脏,肝脏靶向基因疗法可挽救其脑表型和致死表型。

研究设计与样本

  • 使用赖氨酸分解代谢通路敲除小鼠及肝细胞移植的一系列实验。
  • 采用两种肝脏靶向基因疗法:腺相关病毒替换缺陷Gcdh基因,或CRISPR删除Aass基因。

主要发现

  • 脑内毒性GA-1代谢物起源于肝脏。
  • AAV介导的Gcdh基因替换挽救了GA-1小鼠模型的脑表型和致死表型。
  • CRISPR删除Aass基因阻断赖氨酸降解通路同样挽救了GA-1小鼠模型的脑表型和致死表型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Glutaric aciduria type I (GA-1) is an inborn error of metabolism with a severe neurological phenotype caused by the deficiency of glutaryl-coenzyme A dehydrogenase (GCDH), the last enzyme of lysine catabolism. Current literature suggests that toxic catabolites in the brain are produced locally and do not cross the blood-brain barrier. In a series of experiments using knockout mice of the lysine catabolic pathway and liver cell transplantation, we uncovered that toxic GA-1 catabolites in the brain originated from the liver. Moreover, the characteristic brain and lethal phenotype of the GA-1 mouse model was rescued by two different liver-directed gene therapy approaches: Using an adeno-associated virus, we replaced the defective Gcdh gene or we prevented flux through the lysine degradation pathway by CRISPR deletion of the aminoadipate-semialdehyde synthase (Aass) gene. Our findings question the current pathophysiological understanding of GA-1 and reveal a targeted therapy for this devastating disorder.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Barzi M, Johnson CG, Chen T, et al. Rescue of glutaric aciduria type I in mice by liver-directed therapies. Sci Transl Med. 2023. PMID: 37075130. doi:10.1126/scitranslmed.adf4086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。